XML 92 R76.htm IDEA: XBRL DOCUMENT
v3.26.1

Stockholders' Equity (Deficit) - Offerings (Details) - USD ($) |  |  |  |  |  |  |  |  |  |  |  |  | 1 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jan. 17, 2025 | Jan. 16, 2025 | Dec. 11, 2024 | Dec. 05, 2024 | Nov. 25, 2024 | Nov. 24, 2024 | Oct. 01, 2024 | Sep. 30, 2024 | Aug. 21, 2024 | Jul. 01, 2024 | Apr. 08, 2024 | Aug. 24, 2023 | Dec. 31, 2024 | Nov. 30, 2024 | Sep. 30, 2024 | Aug. 31, 2024 | Jul. 31, 2024 | Apr. 30, 2024 | Dec. 31, 2025 | Dec. 31, 2024
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price |  |  |  |  | $ 0.008 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant modification and additional warrants - incremental value |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 858,270 |  | $ 2,868,000 | [1]
Proceeds from issuance of common stock |  |  |  |  |  |  |  |  |  | $ 5,100,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Number of common shares issued |  |  |  |  |  |  |  |  |  | 160,624 |  |  |  | 137,500 | 112,500 | 107,875 | 160,624 | 94,697 | 40,297 |  |  | 653,493 |
Shares Issued price per share |  |  |  |  |  |  |  |  |  | $ 32 |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrant |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Repriced - New |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 5.27 |  |  |
Net proceeds from At-the-Market Offering Program |  |  |  |  |  |  |  |  |  | $ 4,500,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Adjustments to additional paid in capital upon stock issuance costs | [2] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 2,868,000 |
Proceeds from exercise of stock warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 3,892,473 |  | $ 1,223 |
Registered Direct Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds |  |  |  |  |  |  |  |  |  |  |  | $ 1,900,000 |  |  |  |  |  |  |  |  |  |  |
Number of shares of common stock offering |  |  |  |  |  |  |  |  |  |  |  | 40,297 |  |  |  |  |  |  |  |  |  |  |
Share Price |  |  |  |  |  |  |  |  |  |  |  | $ 49.63 |  |  |  |  |  |  |  |  |  |  |
Proceeds from issuance of common stock |  |  |  |  |  |  |  |  |  |  |  | $ 2,000,000 |  |  |  |  |  |  |  |  |  |  |
July offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued |  |  |  |  |  |  |  |  |  |  | 94,697 |  |  |  |  |  |  |  |  |  |  |  |
Exercise price |  |  |  |  |  |  |  |  |  |  | $ 55.2 |  |  |  |  |  |  |  |  |  |  |  |
Number of common shares issued |  |  |  |  |  |  |  |  |  |  | 94,697 |  |  |  |  |  |  |  |  |  |  |  |
Shares Issued price per share |  |  |  |  |  |  |  |  |  |  | $ 52.8 |  |  |  |  |  |  |  |  |  |  |  |
Additional warrants |  |  |  |  |  |  |  |  |  |  | 21,872 |  |  |  |  |  |  |  |  |  |  |  |
Term of warrant |  |  |  |  |  |  |  |  |  |  | 6 months |  |  |  |  |  |  |  |  |  |  |  |
Aggregate gross proceeds |  |  |  |  |  |  |  |  |  |  | $ 5,000,000 |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds from At-the-Market Offering Program |  |  |  |  |  |  |  |  |  |  | 4,300,000 |  |  |  |  |  |  |  |  |  |  |  |
Placement agent fees |  |  |  |  |  |  |  |  |  |  | 400,000 |  |  |  |  |  |  |  |  |  |  |  |
Legal fees |  |  |  |  |  |  |  |  |  |  | 300,000 |  |  |  |  |  |  |  |  |  |  |  |
Adjustments to additional paid in capital upon stock issuance costs |  |  |  |  |  |  |  |  |  |  | $ 2,900,000 |  |  |  |  |  |  |  |  |  |  |  |
September 2024 Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price |  |  |  |  |  |  |  |  | $ 0.008 |  |  |  |  |  |  | $ 0.008 |  |  |  |  |  |  |
Net proceeds |  |  |  |  |  |  |  |  | $ 4,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of common shares issued |  |  |  |  |  |  | 112,500 |  | 107,875 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares Issued price per share |  |  |  |  |  |  |  |  | $ 36.8 |  |  |  |  |  |  | $ 36.8 |  |  |  |  |  |  |
Term of warrant |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |
Net proceeds from At-the-Market Offering Program |  |  |  |  |  |  |  |  | $ 3,600,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price of Warrants |  |  |  |  |  |  |  |  | $ 36.79 |  |  |  |  |  |  | $ 36.79 |  |  |  |  |  |  |
November 2024 Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price |  |  |  |  |  |  | $ 0.008 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from issuance of common stock |  |  |  |  |  |  | $ 1,300,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of common shares issued |  |  |  |  |  |  | 112,500 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares Issued price per share |  |  |  |  |  |  | $ 8.608 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrant |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds from At-the-Market Offering Program |  |  |  |  |  |  | $ 1,100,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price of Warrants |  |  |  |  |  |  | $ 8.6 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
December 2024 Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from issuance of common stock |  |  |  |  | $ 1,900,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of common shares issued |  |  |  |  | 137,500 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares Issued price per share |  |  |  |  | $ 7.752 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds from At-the-Market Offering Program |  |  |  |  | $ 1,700,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price of Warrants |  |  |  |  | $ 7.744 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price |  |  |  |  |  |  |  |  |  |  |  |  | $ 148.8 |  |  |  |  |  |  |  |  |  |
Number of common shares issued | [3] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 653,493 |
Issuance of common stock from exercise of warrants (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (502,125) | [4] | 152,905 |
Pre-funded warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 197,118 |  |  |
Exercise price |  |  |  |  |  |  |  |  |  |  |  |  | 148 |  |  |  |  |  |  |  |  |  |
Repriced - New |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 5.27 |  |  |
Pre-funded warrants | September 2024 Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price |  |  |  |  |  |  |  | $ 0.008 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock from exercise of warrants (in shares) |  |  |  |  |  |  |  | 821 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Pre-funded warrants | November 2024 Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price |  |  |  |  |  | $ 0.008 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock from exercise of warrants (in shares) |  |  |  |  |  | 38,522 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Pre-funded warrants | December 2024 Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price |  |  |  | $ 0.008 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock from exercise of warrants (in shares) |  |  |  | 113,563 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Pre-funded warrants | Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price |  |  |  |  |  |  |  |  |  |  |  |  | $ 5.272 |  |  |  |  |  |  |  |  |  |
Equity offering august 2023 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds |  |  |  |  |  |  |  |  |  |  |  |  | $ 10,900,000 |  |  |  |  |  |  |  |  |  |
Equity offering august 2023 | Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,100,000 |  |  |  |  |  |  |  |  |  |
Warrants | September 2024 Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price |  |  |  |  |  |  |  |  | $ 40 |  |  |  |  |  |  | $ 40 |  |  |  |  |  |  |
Warrants | November 2024 Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price |  |  |  |  |  |  | $ 8.608 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants | December 2024 Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price |  |  |  |  | $ 7.752 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Prior Warrants | July offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued |  |  |  |  |  |  |  |  |  |  | 129,828 |  |  |  |  |  |  |  |  |  |  |  |
Exercise price |  |  |  |  |  |  |  |  |  |  | $ 178.4 |  |  |  |  |  |  |  |  |  |  |  |
Exercise price |  |  |  |  |  |  |  |  |  |  | 197.6 |  |  |  |  |  |  |  |  |  |  |  |
Repriced - New |  |  |  |  |  |  |  |  |  |  | $ 55.2 |  |  |  |  |  |  |  |  |  |  |  |
Existing Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued |  |  | 394,236 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 197,118 |  |  |
Exercise price |  |  | $ 5.272 |  |  |  |  |  |  |  |  |  |  | $ 55.2 |  |  |  |  |  | $ 55.2 |  | $ 55.2 |
Term of warrant |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued |  |  | 197,118 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds from warrant exercises |  | $ 1,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Existing Warrants | Common Class A |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued |  |  | 197,118 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Existing Warrants | Common Class B |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued |  |  | 197,118 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Existing Warrants | Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from exercise of stock warrants |  | $ 900,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum | Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued |  |  |  |  |  |  |  |  |  |  |  |  | 60,484 |  |  |  |  |  |  |  |  |  |
Maximum | Pre-funded warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued |  |  |  |  |  |  |  |  |  |  |  |  | 52,483 |  |  |  |  |  |  |  |  |  |
Maximum | Pre-funded warrants | September 2024 Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued |  |  |  |  |  |  | 38,522 |  | 821 |  |  |  |  |  |  | 821 |  |  |  |  |  |  |
Maximum | Pre-funded warrants | November 2024 Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued |  |  |  |  |  |  | 38,522 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum | Pre-funded warrants | December 2024 Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued |  |  |  |  | 113,563 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum | Warrants | September 2024 Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued |  |  |  |  |  |  | 302,045 |  | 108,696 |  |  |  |  |  |  | 108,696 |  |  |  |  |  |  |
Minimum | Pre-funded warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued |  |  |  |  |  |  |  |  |  |  |  |  | 28,162 |  |  |  |  |  |  |  |  |  |
Minimum | Pre-funded warrants | November 2024 Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued |  |  |  |  |  |  | 302,045 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Minimum | Pre-funded warrants | December 2024 Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued |  |  |  |  | 502,126 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Minimum | Warrants | September 2024 Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued |  |  |  |  |  |  |  |  | 108,696 |  |  |  |  |  |  | 108,696 |  |  |  |  |  |  |
[1] | Offering includes modification of warrants and additional warrants in the July 2024 offering.
[2] | Non-cash warrant modification and additional warrants issuance costs related to one of the offerings are shown on a separate line item for clarity.
[3] | Includes gross proceeds of $19,385,015, less total cash issuance costs of $2,373,693.
[4] | Partial exercise of the Armistice warrants.

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References No definition available. + Details
Name: | hypd_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights2
Namespace Prefix: | hypd_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average exercise price of warrants or rights new repriced. + References No definition available. + Details
Name: | hypd_ClassOfWarrantOrRightNewRepricedWeightedAverageExercisePrice
Namespace Prefix: | hypd_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of additional securities into which the Additional class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References No definition available. + Details
Name: | hypd_ClassOfWarrantOrRightNumberOfAdditionalSecuritiesCalledByAdditionalWarrantsOrRights
Namespace Prefix: | hypd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Price per share or per unit of warrants or rights outstanding. + References No definition available. + Details
Name: | hypd_ClassOfWarrantOrRightPriceOfWarrantsOrRights
Namespace Prefix: | hypd_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of warrants issued during the period. + References No definition available. + Details
Name: | hypd_ClassOfWarrantsOrRightsNumberOfWarrantsIssued
Namespace Prefix: | hypd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Gross cash inflow from exercise of warrants. + References No definition available. + Details
Name: | hypd_GrossProceedsFromWarrantExercises
Namespace Prefix: | hypd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of expense provided in the period for placement agent fees in connection with offering. + References No definition available. + Details
Name: | hypd_PlacementAgentFees
Namespace Prefix: | hypd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from the additional capital contribution net of issuance costs to the entity. + References No definition available. + Details
Name: | hypd_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
Namespace Prefix: | hypd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Aggregate number of shares of common stock offering + References No definition available. + Details
Name: | hypd_StockIssuedDuringPeriodSharesOfferings
Namespace Prefix: | hypd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares issued as a result of the exercise of warrants. + References No definition available. + Details
Name: | hypd_StockIssuedDuringPeriodSharesWarrantsExercised
Namespace Prefix: | hypd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. References + References No definition available. + Details
Name: | hypd_StockholdersEquityLineItems
Namespace Prefix: | hypd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 25 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481284/470-20-25-2 + Details
Name: | us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Subparagraph (k) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(6)) -SubTopic 10 -Topic 220 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_LegalFees
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from the additional capital contribution to the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 + Details
Name: | us-gaap_ProceedsFromIssuanceOrSaleOfEquity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromWarrantExercises
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Cash received on stock transaction after deduction of issuance costs. + References No definition available. + Details
Name: | us-gaap_SaleOfStockConsiderationReceivedOnTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Price of a single share of a number of saleable stocks of a company. + References No definition available. + Details
Name: | us-gaap_SharePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=hypd_RegisteredDirectOffering2024Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=hypd_JulyOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=hypd_September2024OfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=hypd_November2024OfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=hypd_December2024OfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=hypd_PrefundedWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=hypd_EquityOfferingAugust2023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=hypd_PriorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=hypd_ExistingWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |